KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,980,000 | +66.2% | 57,682 | +25.8% | 0.26% | +48.6% |
| Q1 2017 | $3,598,000 | +76.7% | 45,842 | +1.0% | 0.18% | +69.9% |
| Q4 2016 | $2,036,000 | -21.1% | 45,402 | -1.8% | 0.10% | -23.7% |
| Q3 2016 | $2,581,000 | +25.9% | 46,213 | +12.7% | 0.14% | +14.4% |
| Q2 2016 | $2,050,000 | +10.5% | 41,001 | +1.4% | 0.12% | +10.3% |
| Q1 2016 | $1,856,000 | -23.8% | 40,421 | +2.2% | 0.11% | -23.0% |
| Q4 2015 | $2,437,000 | +92.6% | 39,545 | +74.0% | 0.14% | +69.5% |
| Q3 2015 | $1,265,000 | – | 22,725 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |